Symptomatic Subcapsular and Perinephric Hematoma Following Ureteroscopic Lithotripsy for Renal Calculi by Kozminski, Michael A. et al.
Ureteroscopy and Percutaneous Procedures
Symptomatic Subcapsular and Perinephric Hematoma
Following Ureteroscopic Lithotripsy for Renal Calculi
Michael A. Kozminski, MD, David J. Kozminski, BA, William W. Roberts, MD,
Gary J. Faerber, MD, John M. Hollingsworth, MD, MS, and J. Stuart Wolf, Jr., MD
Abstract
Objective: Ureteroscopic lithotripsy (URSL) is believed to be associated with less risk of symptomatic renal
hematoma than extracorporeal shockwave lithotripsy (SWL) and percutaneous nephrolithotomy (PCNL). We
sought to document the rate of and risk factors for this rare complication following URSL for renal calculi.
Methods:With Institutional Review Board approval, we reviewed 1087 cases of URSL performed between July
2009 and October 2012 for four surgeons. We identified cases for renal calculi complicated by symptomatic
‘‘hematoma’’ by searching electronic medical records of patients undergoing URSL with a web-based search
tool and cross-referencing with a departmental quality improvement database for postoperative complications.
Chi-squared tests were used to assess risk factors.
Results: Among 877 renal units exposed to URSL for renal calculi, 4 were complicated by symptomatic
subcapsular hematomas (SH) and 3 by symptomatic perinephric hematomas (PH), yielding a 0.5% and 0.3%
rate for each complication, respectively. Pain was the primary presenting symptom. Almost all cases presented
within 24 to 48 hours postop. Two PH patients required postoperative blood transfusion. Four patients (two SH,
two PH) were hospitalized for observation. Ureteral sheaths were used in two cases (one PH and one SH). There
was no association with age, diabetes, body mass index (BMI), or operative duration ( p-values all > 0.05).
However, hematoma did correlate with female gender, preoperative hypertension, preoperative ureteral stent-
ing, intraoperative ureteral sheath use, and postoperative ureteral stenting (all p-values< 0.0001).
Conclusions: While symptomatic hematoma is a complication of URSL, the rate of such outcome (0.8%) is far
less than that reported by prior series with SWL and PCNL. This may partially be attributable to collection
biases, where subclinical cases are not imaged, or anchoring biases, where clinicians attribute symptoms to
another possible etiology. This outcome can be morbid, but can often be conservatively managed with
observation.
Introduction
Ureteroscopic lithotripsy (URSL) with holmi-um:yttrium-aluminum-garnet (Ho:YAG) laser is con-
sidered an effective and safe method of managing renal
stones.1 Endoscopic advances, including smaller caliber ur-
eteroscopes with greater flexibility, have yielded relatively
low complication rates for URSL.2 Major complications tend
to be rare,3 making URSL preferable compared to percutane-
ous nephrolithotomy (PCNL) or extracorporeal shockwave
lithotripsy (SWL) for more complex patients (e.g., obese,
bleeding diatheses).
Through our practice, we have encountered anecdotal
cases of symptomatic, postoperative renal bleeding following
URSL, specifically perinephric hematoma (PH) and sub-
capsular hematoma (SH). This acute hemorrhage can have
compressive effects on the renal parenchyma, at least theo-
retically compromising renal function and hemodynamics.4 It
has been previously demonstrated that these account for only a
small percentage of postoperative sequelae and tend to occur
far less frequently than in patients undergoing either PCNL or
SWL.2,3 Consequently, the current literature focuses heavily
on outcomes from these latter two stone treatments.5–9 Only a
handful of authors have reported on hematoma as a postop-
erative outcome in URSL, and fewer still have attempted to
qualify risk factors for the development of SH and PH.2,10,11
For these reasons, we sought to determine our own insti-
tutional rate of this rare complication and to determine po-
tential risk factors. We hypothesized, given previous studies,
that symptomatic hematoma rates would be low, and man-
agement of hematoma patients could be conservative with
observation.
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Patients and Methods
With approval from the University of Michigan Medical
Institutional Review Board, we retrospectively reviewed our
departmental database of ureteroscopic procedures per-
formed between July 2009 and October 2012 by four sur-
geons (Fig. 1). In total, 1087 cases were identified for
‘‘lithotripsy.’’ A web-based search tool12 was employed to
identify which of these cases were complicated by symp-
tomatic ‘‘hematoma’’ based on review of clinical care notes,
operative dictations, and radiology reports. All of the iden-
tified symptomatic ‘‘hematoma’’ cases had documented PH
or SH based on computed tomography or sonography as
confirmed by finalized radiology dictations. This search was
also cross-referenced with a departmental quality improve-
ment database for postoperative complications to improve the
sensitivity of our search for symptomatic cases. The remaining
1077 uncomplicated cases were individually reviewed, after
which 15 cases were ultimately excluded from analysis for
either use of holmium laser for an urothelial tumor, blood clot,
or encrusted indwelling stent; endoscopy within a neobladder
chimney; concomitant PCNL; or failure to use a laser. Of the
remaining 1062, 120 patients had bilateral URSL. On initial
analysis of the data, no patients who underwent URSL ex-
clusively for ureteral calculi suffered SH or PH. Since our
presumption was that work in the kidney, not the ureter, results
in the hematoma, we finally excluded all cases involving only
ureteral calculi, which yielded a total of 877 renal units that
were exposed to URSL for renal calculi.
Electronic medical records were reviewed for periopera-
tive data. Patient-specific demographics, including age, sex,
body mass index, preoperative hypertension, and diabetes
mellitus were taken from preop anesthesia evaluations. Op-
erative dictations were individually reviewed for stone la-
terality, stone location, and ureteral sheath/stent utilization.
Operative duration was calculated from anesthesia records
and intraoperative nursing reports.
All patients were counseled and informed consent was
obtained preoperatively. Procedures were performed under
general anesthesia in dorsal lithotomy position. Both Olym-
pus semi-rigid, for distal ureteral calculi, and URF-P5 flexi-
ble, for proximal ureteral and renal calculi, ureteroscopes
were utilized. A 200 or 300 lm (for distal ureteral calculi)
Ho:YAG laser fiber was used for lithotripsy, with the laser
energy of 0.8 to 1.0 J and a frequency of 8 to 10Hz (with
modifications to these settings at the discretion of the sur-
geon). Normal saline irrigant was utilized in all cases with
irrigation pressure at the discretion of the surgeon (usually
150–200mmHg, occasionally up to 300mmHg). The goal of
lithotripsy either was to fragment all visualized stones to less
than 1mm in greatest diameter or to extract any fragments
greater than 1mm. In general, with the former strategy,
ureteral access sheaths were not employed; whereas with the
latter strategy, they were used routinely. Percuflex double
pigtail indwelling ureteral stents (Boston Scientific Cor-
poration, Natick, MA), 6F, were postoperatively utilized
based on surgeon’s discretion. Generally, patients were dis-
charged the same day as the procedure. Renal hematoma—
either subcapsular or perinephric—was diagnosed after the
presentation of symptoms or with adequate clinical suspi-
cion, on the basis of either sonographic or computed tomo-
graphic imaging.
Potential risk factors were compared using bivariate analysis
between patients with and without PH and SH. Chi-squared
tests were used to assess categorical data (gender, laterality,
comorbidity status, sheath use, and stent use). For continuous
variables (age, body mass index, and operation duration), data
were ranked and then divided into two groups. The ratio of
hematoma to no hematoma was then assessed using Chi-
squared tests. Both mean and median were utilized to divide
the samples, but no differencewas demonstrated between these
stratifications. Stone location was analyzed using Pearson’s
chi-squared test. All tests were two-sided, and a p-value of less
than 0.05 was considered statistically significant.
Results
We identified cases of symptomatic, postoperative renal
bleeding following URSL, specifically PH and SH. Figure 2
demonstrates computed tomographic images of both the for-
mer (Fig. 2A), in which blood extravasates outside the renal
capsule and into the retroperitoneal space, and the latter (Fig.
2B), were extravasated blood is retained within the renal
capsule. Among 877 renal units analyzed, 4 were complicated
by SH and 3 by PH, yielding a 0.5% and 0.3% rate for each
complication, respectively. None of these index patients were
anticoagulated at the time of their procedures, aside from as-
pirin or nonsteroidal anti-inflammatory use. There was no
FIG. 1. Description of
Cohort.
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association with age, diabetes mellitus, bodymass index (BMI),
or operative duration (p-values all >0.05). However, hematoma
did significantly correlate with female gender, preoperative
hypertension (defined by preop anesthesia evaluation), preop-
erative ureteral stenting, intraoperative ureteral sheath use, and
postoperative ureteral stenting (all p-values< 0.0001) (Table 1).
Pain was the primary presenting symptom. Almost all
cases presented within 24 to 48 hours postop. We did identify
a single patient who presented*1 month after surgery with
nausea, weight loss, and midline abdominal pain. Two PH
patients required postoperative blood transfusion. Four pa-
tients (two SH cases, and the two PH cases that required blood
FIG. 2. Perinephric (A)
and subcapsular hematomas
(B).
Table 1. Bivariate Analyses of Perioperative Factors
Characteristic Total Nonhematoma Hematoma p-Value
Age (mean, SD) in years 48.0 (14.8) 48.0 (14.9) 50.9 (9.7) 0.5
Gender (% male) 47 47.2 14.3 < 0.001
Body mass index (mean, SD) 31.2 (10.1) 31.1 (10.1) 39 (17.0) 0.6
Preop comorbidities (%)
Diabetes mellitus 19 19.1 14.3 0.2
Hypertension 42.4 42.2 71.4 < 0.001
Stone laterality (% left) 50.6 50.8 57.1 0.2
Stone location (n) 0.9
Kidney only 741 735 6
Ureter and kidney 136 135 1
Operation duration (min) 43.4 (26.5) 43.3 (26.6) 47.7 (16.8) 0.4
Preop ureteral stent (%) 27.2 27.1 42.9 < 0.001
Intraop ureteral sheath (%) 12.8 12.6 28.6 < 0.001
Postop ureteral stent (%) 50.4 50.1 85.7 < 0.001
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transfusions) were hospitalized. Ureteral access sheaths were
used in two cases (one PH, one SH) (Table 2). None of our
index cases seemed to develop ileus after developing a he-
matoma. Five of the seven patients had at least two prior
URSL procedures on the ipsilateral kidney, and two of those
five patients also had at least one PCNL on the affected side
prior to their hematoma episode. Stone size in the index cases
ranged from 1 up to 10mm in greatest diameter. Five patients
had multiple stones; the patients with solitary calculi had a
stone diameter of 5mm. Stones were located in various lo-
cations, including the renal pelvis and both upper and lower
poles. In terms of complicating intraoperative issues, two
operative reports describe large clots within the renal col-
lecting system (upper pole calyx in one case and renal pelvis
in the other); another case had severe collecting system di-
lation with difficult visualization within the cavernous space;
the stone was pushed into renal parenchyma in another
case; one procedure included an infundibulotomy to access
calculi; and another procedure included papillotomies in
addition to lithotripsy.
Discussion
Through a retrospective review of 877 renal units, we
defined the low incidence of symptomatic PH and SH after
URSL for renal calculi. With bivariate analysis, we identified
perioperative risk factors for this outcome. Specifically, we
found that female gender, preoperative hypertension, pre-
operative ureteral stenting, intraoperative ureteral access
sheath use, and postoperative ureteral stenting all have a
significant association ( p < 0.0001) with renal hematoma.
Understanding how these factors may increase the likeli-
hood of developing postoperative hematoma is important for
any urologist managing patients with renal calculi. Pre-
operative hypertension as a risk factor is consistent with prior
experience, as this has also been found to increase the risk of
retroperitoneal bleeding following SWL.5,6 Hypertension
may increase the propensity to hemorrhage after URSL-
induced injury or, in the case of hypertensive nephropathy,
the renal tissue itself may have a greater tendency to damage.
Female gender may relate to hormonal changes that can have
an effect on ureteral peristalsis or pressure, but may also be an
artifact secondary to our small number of events, especially
given that most of the women who were found to have
hematomas were peri- and postmenopausal. Interestingly,
another recent retrospective analysis found a female pre-
dominance among their identified SH (six out of eight
cases).13
The effect of ureteral stents and ureteral access sheaths on
hematoma formation seems less intuitive, but these measures
may instead be surrogates for other factors that are difficult to
assess. For instance, preoperative stents are typically placed
in the setting of obstruction or ureteral narrowing. These
cases are frequently associated with some degree of hydro-
nephrosis, and this distension may weaken the renal unit,
making it more susceptible to pronounced bleeding. Un-
fortunately, many of our procedures are only preceded by
KUB imaging (an abdominal x-ray focusing on the ‘‘kidney-
ureter-bladder’’), which limits the assessment of pelvica-
liectasis, especially in those patients who did not have a
preoperative ureteral stent. Given institutional practice pat-
terns, the use of intraoperative ureteral access sheaths is
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typically reserved for cases with a greater degree of stone
burden and/or harder stones. This would seem to correlate
with a greater degree of laser utilization and overall stone
manipulation, which is difficult to objectively measure. Al-
ternatively, the placement of the sheath itself may injure the
renal parenchyma; however, this was never directly observed
in any of our index cases. Finally, again based on institutional
practice, postoperative stents are typically placed during
cases that were prolonged, had intraoperative bleeding, had
increased stone burden, or had ureteral narrowing or trauma
that may have inhibited renal drainage following the opera-
tion. This could be another marker of case complexity, sim-
ilar to intraoperative ureteral access sheath use, and the more
significant factor could potentially be born out in a multi-
variable analysis, which we were unable to perform here
given our low number of events. Our study is the first to
implicate any of these variables as risk factors for post-USRL
hematoma, and given the frequent use of pre and postoper-
ative stenting and ureteral access sheath use in general, these
data have immediate clinical relevance.
In previous case reports, the chief complaint of renal he-
matoma was flank pain.2,10,11,14 Our study corroborated this
finding; those patients who were symptomatic all presented
with pain. The delayed hematoma case was identified on
computed tomography during evaluation of nausea, weight
loss, and abdominal cramping. This patient required no
postoperative intervention. Patients may also present with
fever, palpable renal mass, increased creatinine, or decreased
hemoglobin. Associated symptoms may include gross he-
maturia, diffused abdominopelvic pain, and hypotension.
While prior reports have described interventions to evacuate
the hematoma,2,11,14 we found that PH and SH can be con-
servatively managed with observation. Of our seven hema-
toma cases, only two required blood transfusions, one was
admitted at an outside hospital, one was taken to the oper-
ating room for an incorrectly positioned ureteral stent, and
none required surgery to drain the hematoma.
SH and PH are rare URSL postoperative outcomes. We
found that together they occur in only 0.8% of URSL cases
for renal calculi. Yet, this low rate may be partially attrib-
utable to certain biases. First, patients who experience min-
imally symptomatic or asymptomatic hematomas may not
present for evaluation or undergo imaging to identify
bleeding. We typically assess patients following URSL with
KUB. As such, subclinical hematomas, if present, are likely
to be undetected. Additionally, clinicians may succumb to
anchoring bias, where the patient’s symptoms are attributed
to other etiologies (e.g., ‘‘stent pain’’) as opposed to the un-
derlying hematoma. These phenomena may also result in an
under diagnosis of post-USRL hematoma. However, as this
study suggests, even symptomatic hematomas rarely require
intervention, so there is unlikely to be a benefit to screening
asymptomatic patients.
Our study may have other limitations. First, there were a
number of factors that have been previously suggested as risk
factors for SH, including stone size and irrigation pressure,14
that were not assessed in our study since these are not con-
sistently measured at our institution. However, we do not feel
that stone size is a modifiable perioperative variable. One
may argue that a patient with a larger stone size may be
counseled toward PCNL rather than URSL. However, it is
known that PCNL carries a higher risk of retroperitoneal
hemorrhage, and for other surgical and/or medical reasons
may not be preferred. Moreover, our institution uses inflat-
able pressurized infusion bags that only roughly approximate
irrigant pressures. Higher irrigant pressures dilate the upper
tract to a greater degree and potentially placed an increased
stress on the given renal unit. However, in many cases, es-
pecially those complicated by poor visualization, higher ir-
rigant pressures may be necessary to prevent mucosal injury
during lithotripsy. Additionally, we did not include any laser
parameters in our analysis, but again, these are typically
adapted to treat the stone at hand, and the surgeon would be
unlikely to change them intraoperatively to decrease hema-
toma risk in the face of inadequately treating the stone (and
potentially increasing operative time/complexity).
Conclusions
While symptomatic hematoma is a complication of URSL
for renal calculi, the rate of such outcome (0.8%) is far less
than that reported in other institutional series of SWL and
PCNL. This may partially be attributable to various biases, all
of which may result in under-diagnosis of post-URSL he-
matoma. This outcome can be morbid, but we believe can be
conservatively managed with observation. Urologists can use
this information in counseling patients preoperatively and
guiding evaluation and management of patients who present
with flank pain postoperatively.
Disclosure Statement
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Editorial Comment for Kozminski et al.
Hassan Razvi, MD
The authors performed a single institution retrospec-tive review of 887 renal units subjected to ureteroscopic
lithotripsy procedures for renal calculi to identify the rate
and risk factors for the occurrence of symptomatic renal or
perirenal hematomas. Seven patients were identified, in-
cluding four in whom renal hematoms had developed and
three with perinephric bleeds. All patients presented with
pain, and all but one received a diagnosis within 48 hours of
the procedure. Two patients needed a blood transfusion.
Potential risk factors for hematoma development were
compared using bivariate analysis. Factors identified in the
authors’ analysis that correlated statistically with hematomas
included female sex, preoperative hypertension, preoperative
ureteral stent placement, the use of a ureteral access sheath,
and postprocedure ureteral stent placement. Three of the
seven patients involved intraoperative scenarios that may
have precipitated renal bleeding, including a stone being
pushed into the renal parenchyma, an infundibulotomy, and
papillotomies.
The study methodology precludes the ability to prove cau-
sality for any of the possible risk factors assessed in this report.
As the authors correctly state, the characteristics assessed may
only be surrogates for as yet unrecognized additional factors.
What role do anatomic issues such as thin renal parenchyma
or renal collecting system anomalies play? Could there be
technical issues related to elevated intrarenal pressures gen-
erated by the irrigation fluid with subsequent barotrauma,
or holmium laser shockwave-induced tissue effects? Does
sudden decompression of an obstructed system lead to vas-
cular changes that predispose to hemorrhage?
The authors are to be credited for raising awareness of a
rarely described but possibly underreported phenomenon.
Clearly, further attention should be directed to understanding
the mechanisms and risk factors. This seems to be especially
relevant as the application of flexible ureteroscopy continues
to expand as a primary management option for intrarenal
calculi.
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